Form 8-K - Current report:
SEC Accession No. 0001104659-24-106685
Filing Date
2024-10-07
Accepted
2024-10-07 16:30:40
Documents
14
Period of Report
2024-10-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2425742d1_8k.htm   iXBRL 8-K 24256
2 EXHIBIT 99.1 tm2425742d1_ex99-1.htm EX-99.1 14495
  Complete submission text file 0001104659-24-106685.txt   217242

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lqda-20241007.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lqda-20241007_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lqda-20241007_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2425742d1_8k_htm.xml XML 3652
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39724 | Film No.: 241358184
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)